Loading…
Medical Innovation Never Stops Act of 2019
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
51pct
1d open
vs 9,062 other HR bills in the 116th — cohort avg 39d
Medical Innovation Never Stops Act of 2019 This bill requires the Food and Drug Administration (FDA)to accept and review new medical device applications and associated user fees during a lapse in appropriations.Under current law, the FDA is prohibited from accepting new user fees and reviewing medical device submissions during an appropriations lapse.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (2)
2020 · second_quarter · Health Issues
Medical Device User Fee Act - S.692 Medical Device Access and Innovation Protection Act - section 710 requiring FDA to report on third-party servicing of medical devices. H.R. 1362, Medical Innovation Never Stops Act - All provisions 3rd Party Service regulation - H.R.2118/Medical Device Servicing Safety and Accountability Act (115th Congress) Cybersecurity Artificial Intelligence issues relating to medical devices Information blocking rule from ONC (21st Century Cures Act Sec 4004) Population Health and Connected Care Issues FDA guidance on device re-manufacturing FDA device approval - 510(k) and PMA processes GPO administrative fees Aging in place - connected care and remote patient monitoring HR 2669 - Medical Device Safety Act (all provisions) Healthcare Data Privacy Issues related to COVID-19 pandemic response Capabilities related to COVID-19 pandemic and disaster response and planning Defense Production Act implementation Supply chain legislative proposals Issues related to production and procurement of ventilators
Referred to the Subcommittee on Health.
Referred to the House Committee on Energy and Commerce.
Introduced in House
Congress.gov source codes: 1000, Intro-H
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: $470,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Justice, Dept of (DOJ), Office of the Vice President of the United States, SENATE, Treasury, Dept of, U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA), White House Office
2020 · first_quarter · Health Issues
Medical Device User Fee Act - S.692 Medical Device Access and Innovation Protection Act - section 710 requiring FDA to report on third-party servicing of medical devices. H.R. 1362, Medical Innovation Never Stops Act - All provisions Healthy aging / frail elderly proposal 3rd Party Service regulation - H.R.2118/Medical Device Servicing Safety and Accountability Act (115th Congress) Cybersecurity Artificial Intelligence issues relating to medical devices PL 115-271: SUPPORT for Patients and Communities Act - Implementation of various provisions, including opioid package and ultrasound nerve blocking as an alternative to opioids Information blocking rule from ONC (21st Century Cures Act Sec 4004) Population Health and Connected Care Issues FDA guidance on device re-manufacturing FDA device approval - 510(k) and PMA processes GPO administrative fees Aging in place - connected care and remote patient monitoring HR 2669 - Medical Device Safety Act (all provisions) Possibility of establishing Congressional Sleep Health Caucus Healthcare Data Privacy NPRM on Anti-Kickback Safe Harbor Provision Issues related to COVID-19 pandemic response Capabilities related to COVID-19 pandemic and disaster response and planning Defense Production Act implementation Supply chain legislative proposals Issues related to production and procurement of ventilators
Client expense: $450,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Justice, Dept of (DOJ), Office of the Vice President of the United States, SENATE, Treasury, Dept of, U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA), White House Office
2019 · fourth_quarter · Budget/Appropriations
Issues related to appropriations and user fee funding for the Food and Drug Administration H.R. 1362, the Medical Innovation Never Stops Act, and issues related to FDA operations during a lapse in appropriations
Client expense: $1,750,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2019 · fourth_quarter · Health Issues
Medical Device User Fee Act - S.692 Medical Device Access and Innovation Protection Act - section 710 requiring FDA to report on third-party servicing of medical devices. H.R. 1362, Medical Innovation Never Stops Act - All provisions Healthy aging / frail elderly proposal 3rd Party Service regulation - H.R.2118/Medical Device Servicing Safety and Accountability Act (115th Congress) Cybersecurity Artificial Intelligence issues relating to medical devices PL 115-271: SUPPORT for Patients and Communities Act - Implementation of various provisions, including opioid package and ultrasound nerve blocking as an alternative to opioids Information blocking rule from ONC (21st Century Cures Act Sec 4004) Population Health and Connected Care Issues FDA guidance on device re-manufacturing FDA device approval - 510(k) and PMA processes GPO administrative fees Aging in place - connected care and remote patient monitoring HR 2669 - Medical Device Safety Act (all provisions) Possibility of establishing Congressional Sleep Health Caucus Healthcare Data Privacy
Client expense: $300,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), SENATE, Treasury, Dept of, U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA)
2019 · third_quarter · Health Issues
Medical Device User Fee Act - S.692 Medical Device Access and Innovation Protection Act - section 710 requiring FDA to report on third-party servicing of medical devices. H.R. 1362, Medical Innovation Never Stops Act - All provisions Healthy aging / frail elderly proposal 3rd Party Service regulation - H.R.2118/Medical Device Servicing Safety and Accountability Act (115th Congress) Cybersecurity Artificial Intelligence issues relating to medical devices PL 115-271: SUPPORT for Patients and Communities Act - Implementation of various provisions, including opioid package and ultrasound nerve blocking as an alternative to opioids Information blocking rule from ONC (21st Century Cures Act Sec 4004) Population Health and Connected Care Issues FDA guidance on device re-manufacturing FDA device approval - 510(k) and PMA processes GPO administrative fees Aging in place - connected care and remote patient monitoring HR 2669 - Medical Device Safety Act (all provisions)
Client expense: $420,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), SENATE, Treasury, Dept of, U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA)
2019 · third_quarter · Budget/Appropriations
Issues related to appropriations and user fee funding for the Food and Drug Administration H.R. 1362, the Medical Innovation Never Stops Act, and issues related to FDA operations during a lapse in appropriations
Client expense: $620,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2019 · second_quarter · Budget/Appropriations
Issues related to appropriations and user fee funding for the Food and Drug Administration H.R. 1362, the Medical Innovation Never Stops Act, and issues related to FDA operations during a lapse in appropriations
Client expense: $800,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2019 · second_quarter · Health Issues
Medical Device User Fee Act - S.692 Medical Device Access and Innovation Protection Act - section 710 requiring FDA to report on third-party servicing of medical devices. H.R. 1362, Medical Innovation Never Stops Act - All provisions Healthy aging / frail elderly proposal 3rd Party Service regulation - H.R.2118/Medical Device Servicing Safety and Accountability Act (115th Congress) Cybersecurity Artificial Intelligence issues relating to medical devices PL 115-271: SUPPORT for Patients and Communities Act - Implementation of various provisions, including opioid package and ultrasound nerve blocking as an alternative to opioids Information blocking rule from ONC (21st Century Cures Act Sec 4004) Population Health and Connected Care Issues Upcoming FDA guidance on device re-manufacturing FDA device approval - 510(k) and PMA processes
Client expense: $460,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), SENATE, Treasury, Dept of, U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA)
2019 · first_quarter · Health Issues
Medical Device User Fee Act - S.692 Medical Device Access and Innovation Protection Act and companion legislation in House (to be introduced) H.R. 1362, Medical Innovation Never Stops Act Healthy aging / frail elderly proposal 3rd Party Service regulation - H.R.2118/Medical Device Servicing Safety and Accountability Act Cybersecurity Artificial Intelligence issues relating to medical devices Possible legislation to incentivize/require AEDs in schools H.R.6 - Opioid package and ultrasound nerve blocking as an alternative to opioids Information blocking rule from ONC (21st Century Cures Act Sec 4004) Population Health and Connected Care Issues Upcoming FDA guidance on device re-manufacturing FDA device approval - 510(k) and PMA processes
Client expense: $250,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), SENATE, U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA)
2019 · first_quarter · Budget/Appropriations
Issues related to appropriations and user fee funding for the Food and Drug Administration H.R. 1362, the Medical Innovation Never Stops Act, and issues related to FDA operations during a lapse in appropriations
Client expense: $710,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE